Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Showing session: reset

Maternal-Child Health and Treatment of Malignancies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 13 of 13
Introduction of Speakers Part 1
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Maternal Tenofovir Prophylaxis With Active Immunization to Prevent Infant Hepatitis B   (ABSTRACT 117)
Gonzague Jourdain
Chiang Mai University, Chiang Mai, Thailand
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Efficacy of Home Visits for Pregnant Couples to Promote Couple HIV Testing and Family Health   (ABSTRACT 118)
Lynae Darbes
University of Michigan, Ann Arbor, MI, USA
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Dolutegravir Does Not Reduce Levonorgestrel or Medroxyprogesterone Acetate Concentrations in WLWH   (ABSTRACT 119)
Rebecca Ryan
Botswana Harvard AIDS Institute Partnership, Gabarone, Botswana
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Lenacapavir Pharmacokinetics, Safety, and Efficacy in Adolescents and Adults in PURPOSE 1   (ABSTRACT 120)
Katherine Gill
Desmond Tutu HIV Foundation, Cape Town, South Africa
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Questions and Answers Part 1
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Introduction of Speakers Part 2
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Assessing IIT and Mortality Among CLHIV <15 yo in PEPFAR-Supported Countries, FY21 - FY24   (ABSTRACT 121)
Michelle Yang
US Department of State, Washington, DC, USA
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Multidose PK/Safety of Dolutegravir Dispersible Tablets & Oral Films in Neonates: PETITE-DTG Study   (ABSTRACT 122)
Adrie Bekker
Stellenbosch University, Cape Town, South Africa
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Genotypic Resistance in the African Paediatric CHAPAS-4 Trial of Second-Line Antiretroviral Therapy   (ABSTRACT 123)
Alasdair Bamford
Great Ormond Street NHS Foundation Trust, London, UK
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Abemaciclib, a CDK4/6 Inhibitor, in HIV-Associated and HIV-Negative Kaposi Sarcoma   (ABSTRACT 124)
Jose R. Mercado-Matos
National Cancer Institute, Bethesda, MD, USA
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Differences in Treatment and Overall Survival in People With and Without HIV and Oropharynx Cancer   (ABSTRACT 125)
Elizabeth Chiao
University of Texas MD Anderson Cancer Center, Houston, TX, USA
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
Questions and Answers Part 2
from CROI 2025 on March 10, 2025 10:00 AM-12:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 13 of 13